Cryoport reported a 14% year-over-year revenue increase to $50.2 million in Q3 2026, driven by a 20% rise in commercial cell and gene therapy revenue and growth across its life sciences services and products. The company supports a record 788 global clinical trials and 23 approved therapies, reflecting strong demand for its temperature-controlled supply chain solutions. Adjusted EBITDA turned positive at $1.1 million, marking progress toward profitability. Cryoport raised its full-year 2026 revenue guidance to $197-$199 million, citing robust clinical pipelines and expanding customer relationships.
Cryoport's Q3 2026 financial results provide context for readers interested in health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Nov 06, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 16 rose and 134 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 9.90 with a -15.02% change, ClearPoint Neuro Inc (CLPT) at USD 8.69 down -14.47%, and SELLAS Life Sciences Group Inc (SLS) at USD 7.85 down -14.11%.
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...
Bitcoin fell from a high of $80,721 on Thursday to around $75,692 early Friday, slipping below its 100-day moving average near $76,950. The decline was linked to a sell-off in tech stocks and coincides with anticipation of the US jobs report due at 2...
Hyperliquid's HYPE token fell 7.8% to around $77, mirroring a broader crypto market decline led by Bitcoin and Ether. The drop is attributed to general market pressure rather than any platform-specific news. Hyperliquid's Assistance Fund holds 48.7 m...
Apple Inc. (AAPL) perpetual contracts on Hyperliquid bounced back near $350 on November 5, recovering from recent losses. A wallet added about $33.22 million to a large short position totaling roughly 150,000 contracts valued at $52.46 million, with ...
